SCHEMBL9468653

SCHEMBL9468653

C/C=C\C(N)C(=O)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALOX15 P16050 1/20 0.41
ALDH1A1 P00352 3/20 0.39
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SOAT1 P35610 1/20 0.36
HCAR2 Q8TDS4 1/20 0.34
CAD P27708 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CPB2 Q96IY4 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9468728 1.00 CYP2D6 (0.47) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL22329028 0.81 CYP2D6 (0.46) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL10755241 0.81 CYP2D6 (0.46) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL25606235 0.78 CYP2D6 (0.44) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL9743805 0.78 CYP2D6 (0.44) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL29253119 0.78 CYP2D6 (0.44) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL9743811 0.78 CYP2D6 (0.44) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL25606084 0.78 CYP2D6 (0.44) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL2915798 0.77 ALDH1A1 (0.42) CYP2D6CYP2C9CYP2C19ALOX15ALDH1A1
SCHEMBL2304908 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5208260-A Vinyl Glycine derivatives for memory and learning enhancement or treatment of a cognitive disorder G. D. SEARLE & CO. (US) 1993-05-04 US disclosed